Skip to main content

Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

Jefferies Raises PT On Merck & Company To $34.50
Joe Young  
 
February 14, 2011 7:51am   Comments
Share:

Jefferies & Company has raised the price target on Merck & Company (NYSE: MRK) from $29.90 to $34.50 and maintains its Hold rating.

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

 

Related Articles (MRK)

Trump Issues 60 Day Ultimatum To US Pharma Giants To Slash Drug Prices: 'If You Refuse To Step Up We Will...'
Cautious Optimism As Merck Leans On Oncology Amid Gardasil Vaccine Concerns
Is Merck & Co Gaining or Losing Market Support?
AMD Rises To 1-Year Highs, Crude Eyes $68: What's Moving Markets Tuesday?
Merck CEO Sees Minimal EU Tariffs Impact, Warns Of Gardasil Challenges
Earnings Scheduled For July 29, 2025
View Comments and Join the Discussion!

Posted-In: Jefferies & Company Merck & CompanyPrice Target Analyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com